Lab-Grown Mini-Tumors could predict best prostate cancer therapy
NCT ID NCT07004582
First seen Jan 29, 2026 · Last updated Jun 22, 2026 · Updated 18 times
Summary
This study aims to find the best way to grow 3D mini-tumors from prostate cancer patients' own tissue. Researchers will compare two lab techniques to see which one can successfully test different treatments on these mini-tumors. The goal is to eventually help doctors choose the most effective treatment for each patient, especially those with aggressive or recurrent prostate cancer. 600 participants will provide tissue samples during their standard care procedures.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Academisch Ziekenhuis Maastricht
NOT_YET_RECRUITINGMaastricht, Limburg, 6229 ET, Netherlands
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
-
Maastricht Radiation Oncology
RECRUITINGMaastricht, Limburg, 6229 ET, Netherlands
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Contact
Contact
-
Zuyderland Medisch Centrum
NOT_YET_RECRUITINGHeerlen, Limburg, 6419 PC, Netherlands
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could lead to a personalized way to predict the most effective treatment for each prostate cancer patient, potentially improving survival and reducing trial-and-error.
What could go wrong
This is an early-stage lab study, not a treatment trial. The techniques may not work reliably for all tumor types, and results may not translate to better patient outcomes in practice.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.